Titan Pharmaceuticals, Inc. Stock OTC Bulletin Board
Equities
TTNP
US8883141017
Pharmaceuticals
Financials (USD)
Sales 2022 | 557K | Sales 2023 | 184K | Capitalization | 6.21M |
---|---|---|---|---|---|
Net income 2022 | -10M | Net income 2023 | -5M | EV / Sales 2022 | 15.6 x |
Net cash position 2022 | 2.75M | Net cash position 2023 | 6.2M | EV / Sales 2023 | 0.11 x |
P/E ratio 2022 |
-1.03
x | P/E ratio 2023 |
-1.11
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 54.53% |
Members of the board | Title | Age | Since |
---|---|---|---|
Avraham Ben-Tzvi
BRD | Director/Board Member | 53 | 22-08-14 |
Gim Shen Seow
CEO | Chief Executive Officer | 42 | 23-10-11 |
Brynner Chiam
BRD | Director/Board Member | - | 23-10-11 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |